Newer LDL-Lowering Drug Shows Excellent Benefit

PCSK9 inhibitors could become the drugs of choice if their prices drop.

In the ongoing effort to find drugs that safely and effectively reduce cardiovascular events, there’s a new class of stars: PCSK9 inhibitors. These drugs are antibodies directed at the PCSK9 protein, which regulates LDL receptor recycling.  Blocking the protein results in increasing the effective number of receptors, which leads to reductions in blood LDL cholesterol […]

Tags , , , , , , , , , , , , , , , , , , , , , , , ,
Comments

Leave a Reply

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×